MedTrace Logo

Measure the Meridian Energy Change of Terminal Hospice Patient Via Meridian Energy Analysis Device

NCT03939221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-08-24

No results posted yet for this study

Summary

In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine and clinical symptoms. First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients. It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, the intervention of complementary and alternative medicine can also monitor via MEAD.

Conditions

  • Hospice
  • Survival
  • Alternative Medicine
  • Skin Electric Conductance

Interventions

BEHAVIORAL

Infrared Lamp and Acupressure

Measure the ankle and wrist acupoints skin conductance to evaluate the basic condition of terminal hospice patients. Then investigators use the infrared lamp and acupressure(tender points, PC6 and ST36 for one minutes) for our patient for the cold limbs, pain control and constipation problems.

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Principal Investigators

  • Ming-Cheng Chung, Bachelor · Changhua Christian Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03939221 on ClinicalTrials.gov